Journal
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
Volume 39, Issue 6, Pages 593-598Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.ijom.2010.02.011
Keywords
botulinum neurotoxin; masseter muscle; temporalis muscle; masticatory muscle atrophy; craniofacial growth and development
Categories
Ask authors/readers for more resources
The purpose of this study was to use botulinum neurotoxin type A (BoNT/A) selectively to evaluate the influence of localized masticatory atrophy and paresis on craniofacial growth and development 60 growing rats, 4 weeks old, weighing approximately 120 g, were randomly divided according as follows (Long-Evans, N = 15 per group) I (Mb + Tns); II (Mns + Tb); III (Mb + Tb), IV (Mns + Tns), where Mb or Tb is the BoNT/A-injected masseter or temporalis muscles (1 0 U/ muscle, 2 5 ml) and Mns or Tns is the saline-injected muscles (2.5 ml). After 7 weeks, the mature rats were killed, the muscles dissected and mean muscle mass recorded Anthropometric cranial, maxillary and mandibular measurements were taken from the dried skulls Changes in animal weight during the growth period were not statistically significant The mean masticatory muscle mass was smaller for the BoNT/A-injected muscles of Mb and Tb. Anthropometric measurements of bony structures inserted by masseter and temporalis muscles revealed a significant treatment effect The measurements showed a facial morphology typical of a dolichofacial profile short upper face accompanied by a long lower face with an extended mandibular length and ramus height and constricted bicoronoidal and bigonial widths The results suggest that induction of localized masticatory muscle atrophy with BoNT/A alters craniofacial growth and development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available